BioNTech Announces Positive Results of an International Reproducibility Study with MammaTyper®
Bioportfolio,
International multicenter study in ten pathology laboratories in the U.S., Canada, Europe and Asia MammaTyper® provides highly…
International multicenter study in ten pathology laboratories in the U.S., Canada, Europe and Asia MammaTyper® provides highly…
• International multicenter study in ten pathology laboratories in the U.S., Canada, Europe and Asia • MammaTyper® provides…
First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC…
Mainz, Germany, July 12, 2016 / B3C newswire / -- BioNTech Diagnostics GmbH announces the publication of new study data which…